Product image of Imunovir (Inosine Pranobex) supplied by GNH India

Imunovir

Active Ingredient:
Inosine Pranobex
Origin:
EU

Imunovir (Inosine Pranobex)

Inosine Pranobex, the active ingredient in Imunovir, is an immunostimulant presented as an oral formulation for oral use. It is employed to support the immune response in viral infections such as herpes simplex, human papillomavirus, and influenza, and in certain immunodeficiency conditions.

GNH India supplies Imunovir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from regulatory support and timely delivery across multiple regions.

Manufacturer / TM Owner

Kora Corporation Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imunovir (inosine pranobex) is used as an antiviral immunostimulant in several viral and immunodeficiency conditions.

  • Herpes simplex infections: Helps shorten the duration of lesions and reduces viral shedding by stimulating T‑lymphocyte activity and natural killer cell function.
  • Human papillomavirus infections: Supports clearance of HPV lesions through enhanced cellular immunity, potentially aiding in regression of warts.
  • Influenza: Contributes to faster symptom resolution and limits viral replication by augmenting the host’s immune defenses.
  • Immunodeficiency states: Provides adjunctive immune support, improving resistance to opportunistic viral infections in patients with compromised immunity.

How It Works

  • Inosine pranobex enhances the host immune response by activating T‑lymphocytes and natural killer cells, increasing cytokine production such as interferon‑γ and interleukin‑2. This immunomodulation improves the ability of immune cells to recognize and eliminate virus‑infected cells, while also exerting direct antiviral effects that interfere with viral replication cycles.

Side Effects

Adverse reactions may occur with oral immunostimulants and should be monitored.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Insomnia: difficulty initiating sleep.
  • Skin rash: mild erythematous eruptions.
  • Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects

  • Severe allergic reaction: anaphylaxis, swelling of face or throat.
  • Hematologic abnormalities: leukopenia or thrombocytopenia requiring medical evaluation.

Precautions & Warnings

Patients should be evaluated for underlying conditions and potential risks before initiating therapy.

  • Pregnancy: safety not established; avoid unless benefits outweigh risks.
  • Breastfeeding: unknown excretion; consider alternative therapy.
  • Liver disease: monitor hepatic function regularly.
  • Renal impairment: dose adjustment may be required under medical supervision.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Inosine pranobex may interact with other medications that affect immune function or hepatic metabolism.

Major Interactions (Avoid)

  • Immunosuppressants (e.g., cyclosporine, tacrolimus): may diminish therapeutic effect.
  • Live vaccines: concurrent use can reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antiviral agents (e.g., acyclovir): potential additive toxicity.
  • Hepatotoxic drugs (e.g., isoniazid): increased risk of liver enzyme elevation.
  • Anticoagulants (e.g., warfarin): possible alteration of coagulation parameters.

Frequently Asked Questions

Imunovir contains inosine pranobex and is indicated for the management of herpes simplex infections, human papillomavirus (HPV) infections, influenza, and as an adjunct in certain immunodeficiency states to help bolster the body’s antiviral defenses.

Inosine pranobex works by stimulating T‑lymphocytes and natural killer cells, increasing cytokine production such as interferon‑γ and interleukin‑2, which together enhance the immune system’s ability to recognize and clear virus‑infected cells while also exerting direct antiviral activity.

The dosage of Imunovir is determined by the prescribing clinician based on the specific indication, patient age, weight, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Imunovir in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare professional.

To order Imunovir, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike many direct‑acting antivirals that target specific viral enzymes, Imunovir acts as an immunostimulant, enhancing the host’s immune response. This broader mechanism can be advantageous in mixed viral infections, but it may be less potent against a single virus compared with agents that inhibit viral replication directly.

Imunovir should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Imunovir is taken orally, usually with a glass of water. The exact administration schedule, such as frequency and timing relative to meals, is determined by the prescribing clinician and should be followed precisely.

Serious adverse events, although rare, can include severe allergic reactions such as anaphylaxis and hematologic abnormalities like leukopenia or thrombocytopenia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or unexplained bruising or bleeding.

Imunovir is contraindicated in individuals with known hypersensitivity to inosine pranobex or any of its excipients. Caution is also advised for patients with severe liver or kidney impairment, uncontrolled autoimmune disorders, or those receiving live vaccines, unless specifically directed by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Inosine Pranobex

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT